Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Wolitzky-Taylor

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Addiction Medicine|February 4, 2022
Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare SystemLarissa J Mooney, Yuhui Zhu, Caroline K Yoo, et al.
Journal of Consulting and Clinical Psychology|January 5, 2018
Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinicsKate Wolitzky-Taylor, Jennifer Krull, Richard Rawson, et al.
Behaviour Research and Therapy|August 11, 2012
Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndromeKate Wolitzky-Taylor, Michelle G Craske, Jennifer S Labus, et al.
Comprehensive Psychiatry|December 16, 2014
Family Accommodation Scale for Obsessive-Compulsive Disorder-Interviewer-Rated (FAS-IR), Brazilian Portuguese version: internal consistency, reliability, and exploratory factor analysisJuliana Braga Gomes, Aristides Cordioli, Barbara Van Noppen, et al.
JAACAP Open|December 19, 2024
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural SettingsJosé M Flores, Emily Kan, Larissa J Mooney, et al.
Journal of Dual Diagnosis|October 1, 2025
Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use DisordersAlan Z Sheinfil, Michael A Cucciare, Kate Wolitzky-Taylor, et al.
Behaviour Research and Therapy|May 26, 2018
Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disordersKate Wolitzky-Taylor, Andrea N Niles, Richard Ries, et al.
Behaviour Research and Therapy|June 1, 2018
Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance usersKate Wolitzky-Taylor, Tess K Drazdowski, Andrea Niles, et al.
Contemporary Clinical Trials|September 20, 2023
Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trialKate Wolitzky-Taylor, Larissa J Mooney, Michael W Otto, et al.
Community Mental Health Journal|March 7, 2018
Stakeholder Perceptions of the Barriers to Receiving and Delivering Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health SettingsKate Wolitzky-Taylor, Bowen Chung, Sarah Kate Bearman, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Addiction Medicine|February 4, 2022
Association Between Benzodiazepine and Opioid Prescription and Mortality Among Patients in a Large Healthcare SystemLarissa J Mooney, Yuhui Zhu, Caroline K Yoo, et al.
Journal of Consulting and Clinical Psychology|January 5, 2018
Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinicsKate Wolitzky-Taylor, Jennifer Krull, Richard Rawson, et al.
Behaviour Research and Therapy|August 11, 2012
Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndromeKate Wolitzky-Taylor, Michelle G Craske, Jennifer S Labus, et al.
Comprehensive Psychiatry|December 16, 2014
Family Accommodation Scale for Obsessive-Compulsive Disorder-Interviewer-Rated (FAS-IR), Brazilian Portuguese version: internal consistency, reliability, and exploratory factor analysisJuliana Braga Gomes, Aristides Cordioli, Barbara Van Noppen, et al.
JAACAP Open|December 19, 2024
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural SettingsJosé M Flores, Emily Kan, Larissa J Mooney, et al.
Journal of Dual Diagnosis|October 1, 2025
Feasibility, Acceptability, and Preliminary Clinical Impact of a Computer-Assisted Transdiagnostic CBT Intervention for Veterans with Co-Occurring Anxiety and Substance Use DisordersAlan Z Sheinfil, Michael A Cucciare, Kate Wolitzky-Taylor, et al.
Behaviour Research and Therapy|May 26, 2018
Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disordersKate Wolitzky-Taylor, Andrea N Niles, Richard Ries, et al.
Behaviour Research and Therapy|June 1, 2018
Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance usersKate Wolitzky-Taylor, Tess K Drazdowski, Andrea Niles, et al.
Contemporary Clinical Trials|September 20, 2023
Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trialKate Wolitzky-Taylor, Larissa J Mooney, Michael W Otto, et al.
Community Mental Health Journal|March 7, 2018
Stakeholder Perceptions of the Barriers to Receiving and Delivering Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health SettingsKate Wolitzky-Taylor, Bowen Chung, Sarah Kate Bearman, et al.
Pageof 6